ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Program Has Top Priority Fink Says

February 9, 1979

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

In Brief: New Spending Plan Funds NIH At FY95 Level; Continuing Resolution Expires Dec. 15

November 24, 1995

NCI Forms New Committees to Oversee Cancer Clinical Trials.

February 17, 2006

Research Funding: Clinton Proposes 2.6% Increase For NIH, Amount Called “Paltry”

February 14, 1997

Funding Opportunities; Program Announcements Released By NCI

May 21, 1999